{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-071452","form_type":"8-K","ticker":"CALC","cik":"0001534133","company_name":"CalciMedica, Inc.","filed_at":"2023-03-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:45.470311+00:00","generated_at":"2026-06-18T02:00:11.048698+00:00","sec_items":["5.07","8.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Graybug stockholders approve merger with CalciMedica; 14-to-1 reverse split effective Mar 17","bullets":["All five proposals approved: share issuance (13.2M for), charter amendment, equity plan, ESPP, and adjournment.","Reverse stock split ratio set at 14-to-1, effective after market close March 17, 2023.","Outstanding shares will reduce from ~22M to ~1.57M; no fractional shares—cash in lieu.","Common stock to trade split-adjusted on Nasdaq under new CUSIP 38942Q 202 starting March 20.","Merger with CalciMedica remains subject to customary closing conditions; no closing date announced."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-071452","json":"https://secwatch.observer/filing/0001193125-23-071452.json","markdown":"https://secwatch.observer/filing/0001193125-23-071452.md","text":"https://secwatch.observer/filing/0001193125-23-071452.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1534133/000119312523071452/0001193125-23-071452-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1534133/000119312523071452/d481564d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-18T02:00:11.048698+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1a839613d94e03aca577f03e43b7ac6c8d1ece93","claim":"CalciMedica, Inc. shareholders approved To approve the CalciMedica 2023 Equity Incentive Plan. at the 2023-03-15 meeting.","evidence_excerpt":"PROPOSAL 3 \"The CalciMedica 2023 Equity Incentive Plan Proposal\": To approve the CalciMedica 2023 Equity Incentive Plan. For Against Abstain 12,085,467 1,957,455 287,613","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1534133/000119312523071452/0001193125-23-071452-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"equity plan"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-03-15"}],"fact_type":"shareholder_vote"},{"claim_id":"38e6892d4d74c027767ae2f5d650a862310b565c","claim":"CalciMedica, Inc. shareholders approved To approve the issuance of Graybug common stock in the Merger and the resulting change of control under the Nasdaq Rules (Share Issuance Proposal). at the 2023-03-15 meeting.","evidence_excerpt":"PROPOSAL 1 \"The Share Issuance Proposal\": To approve the issuance of Graybug common stock in the Merger and the resulting change of control under the Nasdaq Rules. For Against Abstain 13,155,174 1,160,128 15,233","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1534133/000119312523071452/0001193125-23-071452-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"merger approval"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-03-15"}],"fact_type":"shareholder_vote"},{"claim_id":"7afca5dae9a4095fd6f013790935bf67e4a30099","claim":"CalciMedica, Inc. shareholders approved To approve the Amended and Restated Certificate of Incorporation. at the 2023-03-15 meeting.","evidence_excerpt":"PROPOSAL 2 \"The Amended and Restated Certificate of Incorporation Proposal\": To approve the Amended and Restated Certificate of Incorporation. For Against Abstain 13,142,209 1,170,391 17,935","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1534133/000119312523071452/0001193125-23-071452-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"charter amendment"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-03-15"}],"fact_type":"shareholder_vote"},{"claim_id":"a29873a756d9f64f1e73a70d2faabb4f7bde0309","claim":"CalciMedica, Inc. shareholders approved To approve the possible adjournment of the Special Meeting. at the 2023-03-15 meeting.","evidence_excerpt":"PROPOSAL 5 \"Possible Adjournment of the Special Meeting Proposal\": To approve the possible adjournment of the Special Meeting. For Against Abstain 12,820,365 1,424,995 85,175","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1534133/000119312523071452/0001193125-23-071452-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-03-15"}],"fact_type":"shareholder_vote"},{"claim_id":"b9d531187b9ba10b16843625701d245b2278ccc6","claim":"CalciMedica, Inc. shareholders approved To approve the CalciMedica 2023 Employee Stock Purchase Plan. at the 2023-03-15 meeting.","evidence_excerpt":"PROPOSAL 4 \"The CalciMedica 2023 Employee Stock Purchase Plan Proposal\": To approve the CalciMedica 2023 Employee Stock Purchase Plan. For Against Abstain 13,118,277 943,669 268,589","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1534133/000119312523071452/0001193125-23-071452-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"equity plan"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-03-15"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}